SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001274644-12-000023
Filing Date
2012-11-09
Accepted
2012-11-09 16:03:12
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tzym10q3q2012.htm 10-Q 900360
2 EXHIBIT 31.1 tzymexhibit3113q2012.htm EX-31.1 16369
3 EXHIBIT 31.2 tzymexhibit3123q2012.htm EX-31.2 16664
4 EXHIBIT 32.1 tzymexhibit3213q2012.htm EX-32.1 7728
5 EXHIBIT 32.2 tzymexhibit3223q2012.htm EX-32.2 7748
  Complete submission text file 0001274644-12-000023.txt   4677295

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tzym-20120930.xml EX-101.INS 615058
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tzym-20120930.xsd EX-101.SCH 38252
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tzym-20120930_cal.xml EX-101.CAL 45867
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tzym-20120930_def.xml EX-101.DEF 204705
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tzym-20120930_lab.xml EX-101.LAB 408742
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tzym-20120930_pre.xml EX-101.PRE 247451
Mailing Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703
Business Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703 919 474 0020
TRANZYME INC (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35119 | Film No.: 121193672
SIC: 2834 Pharmaceutical Preparations